Clinical Trials Logo

Clinical Trial Summary

This study compares the safety and efficacy of single therapy versus double therapy using the Pellevé™ Wrinkle Treatment System for the treatment of mild to moderate facial wrinkles in Fitzpatrick Skin Types I - IV. Safety is assessed by analysis of adverse events. Efficacy is assessed by change in Fitzpatrick score for facial wrinkles.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01299103
Study type Interventional
Source Ellman International
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date April 2012

See also
  Status Clinical Trial Phase
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02261493 - A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Completed NCT01600729 - Reliability of the Facial Wrinkle Scale in Japanese Subjects N/A
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Completed NCT01777620 - A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides Phase 4
Completed NCT00842062 - Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation Phase 1/Phase 2
Completed NCT04609020 - Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment Phase 4
Completed NCT01608659 - An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A